{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T10:49:12Z","timestamp":1792234152438,"version":"4.4.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.jaad.2007.04.018","type":"journal-article","created":{"date-parts":[[2007,6,20]],"date-time":"2007-06-20T07:19:19Z","timestamp":1182323959000},"page":"604-609","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"title":["Incidence and risk factors for corticosteroid-induced lipodystrophy: A prospective study"],"prefix":"10.1016","volume":"57","author":[{"given":"Laurence","family":"Fardet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Cabane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9leste","family":"Lebb\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Morel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Flahault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2007.04.018_bib1","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1378\/chest.48.3.287","article-title":"Long term (five or more years) administration of corticosteroids in pulmonary diseases","volume":"48","author":"Shubin","year":"1965","journal-title":"Dis Chest"},{"key":"10.1016\/j.jaad.2007.04.018_bib2","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0016-5085(98)70254-9","article-title":"Budesonide versus prednisone in the treatment of active Crohn's disease. The Israeli Budesonide Study Group","volume":"115","author":"Bar-Meir","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaad.2007.04.018_bib3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/gut.41.2.209","article-title":"Oral budesonide is as effective as oral prednisolone in active Crohn's disease. The Global Budesonide Study Group","volume":"41","author":"Campieri","year":"1997","journal-title":"Gut"},{"key":"10.1016\/j.jaad.2007.04.018_bib4","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1067\/mai.2000.109830","article-title":"Risk factors associated with glucocorticoid-induced adverse effects in children with severe asthma","volume":"106","author":"Covar","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2007.04.018_bib5","doi-asserted-by":"crossref","first-page":"106","DOI":"10.7326\/0003-4819-134-2-200101160-00010","article-title":"Combined treatment of giant-cell arteritis with methotrexate and prednisone. A randomized, double-blind, placebo-controlled trial","volume":"134","author":"Jover","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaad.2007.04.018_bib6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1177\/135965350501000105","article-title":"Body fat changes among antiretroviral-naive patients on PI- and NNRTI-based HAART in the Swiss HIV cohort study","volume":"10","author":"Young","year":"2005","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jaad.2007.04.018_bib7","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/01.aids.0000131334.38172.01","article-title":"Antiretroviral therapy, fat redistribution and hyperlipidaemia in HIV-infected children in Europe","volume":"18","author":"European Pediatric Lipodystrophy Group","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.jaad.2007.04.018_bib8","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1046\/j.1468-1293.2003.00159.x","article-title":"HIV lipodystrophy: prevalence, severity and correlates of risk in Australia","volume":"4","author":"Miller","year":"2003","journal-title":"HIV Med"},{"key":"10.1016\/j.jaad.2007.04.018_bib9","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1136\/bmj.313.7053.344","article-title":"Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study","volume":"313","author":"Walsh","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.jaad.2007.04.018_bib10","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0197-2456(98)00015-4","volume":"19","author":"Hercberg","year":"1998","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.jaad.2007.04.018_bib11","first-page":"863","article-title":"Endogenous and exogenous glucocorticoids in cushingoid patients","volume":"16","author":"Benet","year":"1982","journal-title":"Drug Intell Clin Pharm"},{"key":"10.1016\/j.jaad.2007.04.018_bib12","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/ki.1985.31","article-title":"Prednisolone pharmacokinetics in cushingoid and non-cushingoid kidney transplant patients","volume":"27","author":"Bergrem","year":"1985","journal-title":"Kidney Int"},{"key":"10.1016\/j.jaad.2007.04.018_bib13","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/00126334-200309010-00008","article-title":"Gender differences in antiretroviral drug-related adipose tissue alterations. Women are at higher risk than men and develop particular lipodystrophy patterns","volume":"34","author":"Galli","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jaad.2007.04.018_bib14","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0140-6736(00)04056-3","article-title":"Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study","volume":"357","author":"Martinez","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2007.04.018_bib15","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00005792-200303000-00007","article-title":"Clinical features and metabolic derangements in acquired generalized lipodystrophy: case reports and review of the literature","volume":"82","author":"Misra","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaad.2007.04.018_bib16","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1097\/00002030-200212060-00010","article-title":"Increased risk of lipoatrophy under stavudine in HIV-1-infected patients: results of a substudy from a comparative trial","volume":"16","author":"Joly","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.jaad.2007.04.018_bib17","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1097\/00002030-200008180-00020","article-title":"Dietary intake, serum lipids, insulin resistance and body composition in the era of highly active antiretroviral therapy 'Diet FRS Study'","volume":"14","author":"Batterham","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.jaad.2007.04.018_bib18","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/ajcn\/78.4.790","article-title":"High-fiber diet in HIV-positive men is associated with lower risk of developing fat deposition","volume":"78","author":"Hendricks","year":"2003","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jaad.2007.04.018_bib19","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/BF03349774","article-title":"Evidence that high dose cortisol-induced Na+ retention in man is not mediated by the mineralocorticoid receptor","volume":"18","author":"Whitworth","year":"1995","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.jaad.2007.04.018_bib20","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1210\/jcem-72-5-1060","article-title":"Evidence that high dose cortisol-induced Na+ retention in man is not mediated by the mineralocorticoid receptor","volume":"72","author":"Montrella-Waybill","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jaad.2007.04.018_bib21","first-page":"539","article-title":"Host factors may be more important than choice of antiretrovirals in the development of lipoatrophy","volume":"13","author":"McComsey","year":"2003","journal-title":"AIDS Read"},{"key":"10.1016\/j.jaad.2007.04.018_bib22","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/00126334-200301010-00007","article-title":"Incidence of and risk factors for lipoatrophy (abnormal fat loss) in ambulatory HIV-1-infected patients","volume":"32","author":"Lichtenstein","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jaad.2007.04.018_bib23","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","article-title":"A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors","volume":"12","author":"Carr","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.jaad.2007.04.018_bib24","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1210\/jcem.84.6.5740","article-title":"Endocrine and metabolic evaluation of human immunodeficiency virus-infected patients with evidence of protease inhibitor-associated lipodystrophy","volume":"84","author":"Yanovski","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jaad.2007.04.018_bib25","doi-asserted-by":"crossref","unstructured":"Fardet L, Cabane J, Kettaneh A, Lebbe C, Flahault A. Corticosteroid-induced lipodystrophy is associated with features of the metabolic syndrome. Rheumatology (Oxford). 2007 Apr 4.","DOI":"10.1093\/rheumatology\/kem062"},{"key":"10.1016\/j.jaad.2007.04.018_bib26","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/hrt.2003.020180","article-title":"Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study","volume":"90","author":"Souverein","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.jaad.2007.04.018_bib27","doi-asserted-by":"crossref","first-page":"764","DOI":"10.7326\/0003-4819-141-10-200411160-00007","article-title":"Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease","volume":"141","author":"Wei","year":"2004","journal-title":"Ann Intern Med"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096220700775X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096220700775X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:08:02Z","timestamp":1759270082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019096220700775X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S019096220700775X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2007.04.018","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence and risk factors for corticosteroid-induced lipodystrophy: A prospective study","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2007.04.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}